JP Morgan increased its holding of Guangzhou Baiyunshan Pharmaceutical Holdings (00874) by approximately 26,720 shares at a price of around HK$18.9 per share.
On November 3, Xiaomo increased its stake in Baiyunshan (00874) by 267,243 shares, with a price of 18.9038 Hong Kong dollars per share, totaling approximately 5.0519 million Hong Kong dollars.
The latest data from the Hong Kong Stock Exchange shows that on November 3rd, JP Morgan increased its holdings of Guangzhou Baiyunshan Pharmaceutical Holdings (00874) by 267,243 shares, at a price of HK$18.9038 per share, with a total amount of approximately HK$5.0519 million. After the increase, the latest total number of shares held is approximately 17.6993 million shares, and the latest shareholding ratio is 8.04%.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
